Great West Life Assurance Co. Can boosted its position in shares of MiMedx Group Inc. (NASDAQ:MDXG) by 4.1% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 202,096 shares of the company’s stock after buying an additional 7,883 shares during the period. Great West Life Assurance Co. Can’s holdings in MiMedx Group were worth $1,733,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Springbok Capital Management LLC purchased a new stake in shares of MiMedx Group during the first quarter worth approximately $109,000. PineBridge Investments L.P. boosted its stake in shares of MiMedx Group by 8.5% in the second quarter. PineBridge Investments L.P. now owns 12,643 shares of the company’s stock worth $101,000 after buying an additional 992 shares in the last quarter. BlackRock Inc. boosted its stake in shares of MiMedx Group by 71.2% in the second quarter. BlackRock Inc. now owns 12,865 shares of the company’s stock worth $103,000 after buying an additional 5,351 shares in the last quarter. Teacher Retirement System of Texas boosted its stake in shares of MiMedx Group by 26.3% in the second quarter. Teacher Retirement System of Texas now owns 14,361 shares of the company’s stock worth $115,000 after buying an additional 2,994 shares in the last quarter. Finally, Commonwealth Equity Services Inc boosted its stake in shares of MiMedx Group by 15.8% in the second quarter. Commonwealth Equity Services Inc now owns 14,623 shares of the company’s stock worth $117,000 after buying an additional 2,000 shares in the last quarter. Hedge funds and other institutional investors own 51.03% of the company’s stock.

Institutional Ownership by Quarter for MiMedx Group (NASDAQ:MDXG)

Shares of MiMedx Group Inc. (NASDAQ:MDXG) traded down 0.81% during mid-day trading on Tuesday, reaching $9.75. 343,803 shares of the company’s stock traded hands. MiMedx Group Inc. has a 12-month low of $6.64 and a 12-month high of $10.02. The firm has a 50-day moving average of $8.93 and a 200 day moving average of $8.14. The company has a market cap of $1.03 billion, a P/E ratio of 53.87 and a beta of 0.97.

MiMedx Group (NASDAQ:MDXG) last posted its earnings results on Thursday, October 27th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.06. MiMedx Group had a net margin of 8.75% and a return on equity of 18.18%. The firm earned $64.40 million during the quarter, compared to analyst estimates of $63.18 million. During the same quarter in the prior year, the business posted $0.06 EPS. The business’s revenue was up 31.4% compared to the same quarter last year. Equities analysts forecast that MiMedx Group Inc. will post $0.22 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Great West Life Assurance Co. Can Increases Position in MiMedx Group Inc. (MDXG)” was posted by Daily Political and is the propert of of Daily Political. If you are viewing this report on another publication, it was copied illegally and republished in violation of international copyright & trademark legislation. The legal version of this report can be read at http://www.dailypolitical.com/2016/11/29/great-west-life-assurance-co-can-increases-position-in-mimedx-group-inc-mdxg.html.

A number of research firms have recently issued reports on MDXG. Aegis began coverage on shares of MiMedx Group in a research note on Monday, November 7th. They set a “buy” rating and a $12.00 target price for the company. Needham & Company LLC restated a “buy” rating and set a $12.00 target price on shares of MiMedx Group in a research note on Wednesday, August 31st. Finally, Zacks Investment Research cut shares of MiMedx Group from a “hold” rating to a “sell” rating in a research note on Tuesday, November 1st. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $11.18.

In other news, insider William Charles Taylor sold 20,400 shares of the company’s stock in a transaction on Tuesday, September 6th. The shares were sold at an average price of $7.55, for a total value of $154,020.00. Following the completion of the sale, the insider now owns 566,566 shares in the company, valued at approximately $4,277,573.30. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 12.30% of the stock is currently owned by insiders.

About MiMedx Group

MiMedx Group, Inc (MiMedx) is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues and human skin and bone. The Company operates in the Regenerative Biomaterials business segment, which includes the development, processing and marketing of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues in the wound care, surgical, sports medicine, ophthalmic and dental market categories.

5 Day Chart for NASDAQ:MDXG

Want to see what other hedge funds are holding MDXG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MiMedx Group Inc. (NASDAQ:MDXG).

Receive News & Ratings for MiMedx Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.